Nu Skin Enterprises (NYSE:NUS) General Counsel D Matthew Dorny sold 2,000 shares of the firm’s stock in a transaction on Wednesday, April 4th. The shares were sold at an average price of $75.00, for a total transaction of $150,000.00. Following the sale, the general counsel now owns 47,878 shares in the company, valued at $3,590,850. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
D Matthew Dorny also recently made the following trade(s):
- On Monday, April 2nd, D Matthew Dorny sold 3,250 shares of Nu Skin Enterprises stock. The shares were sold at an average price of $72.22, for a total transaction of $234,715.00.
- On Monday, March 5th, D Matthew Dorny sold 3,000 shares of Nu Skin Enterprises stock. The shares were sold at an average price of $72.69, for a total transaction of $218,070.00.
NUS opened at $73.10 on Friday. The firm has a market cap of $3,958.89, a P/E ratio of 23.16, a P/E/G ratio of 2.09 and a beta of 1.36. Nu Skin Enterprises has a fifty-two week low of $52.88 and a fifty-two week high of $75.82. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.74 and a quick ratio of 1.17.
Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, February 15th. The company reported $1.20 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.19 by $0.01. The company had revenue of $666.20 million during the quarter, compared to analysts’ expectations of $667.39 million. Nu Skin Enterprises had a net margin of 5.68% and a return on equity of 25.23%. Nu Skin Enterprises’s quarterly revenue was up 25.4% on a year-over-year basis. During the same period last year, the company posted $0.79 earnings per share. research analysts predict that Nu Skin Enterprises will post 3.56 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 14th. Investors of record on Monday, February 26th were paid a dividend of $0.365 per share. This represents a $1.46 annualized dividend and a yield of 2.00%. This is a boost from Nu Skin Enterprises’s previous quarterly dividend of $0.36. The ex-dividend date of this dividend was Friday, February 23rd. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 45.20%.
Several large investors have recently modified their holdings of NUS. Wolverine Asset Management LLC grew its stake in shares of Nu Skin Enterprises by 106.9% in the 4th quarter. Wolverine Asset Management LLC now owns 1,514 shares of the company’s stock worth $103,000 after buying an additional 23,378 shares in the last quarter. Cerebellum GP LLC purchased a new position in shares of Nu Skin Enterprises in the 4th quarter worth $124,000. Amundi Pioneer Asset Management Inc. purchased a new position in shares of Nu Skin Enterprises in the 4th quarter worth $192,000. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Nu Skin Enterprises by 38.6% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,082 shares of the company’s stock worth $210,000 after buying an additional 858 shares in the last quarter. Finally, Franklin Resources Inc. purchased a new position in shares of Nu Skin Enterprises in the 4th quarter worth $215,000. 76.48% of the stock is owned by institutional investors and hedge funds.
Several analysts have recently commented on the stock. Pivotal Research restated a “buy” rating and set a $90.00 price objective on shares of Nu Skin Enterprises in a research report on Friday, February 16th. ValuEngine raised shares of Nu Skin Enterprises from a “buy” rating to a “strong-buy” rating in a research note on Monday, April 2nd. Zacks Investment Research cut shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Wednesday, December 20th. Stifel Nicolaus raised their target price on shares of Nu Skin Enterprises from $50.00 to $57.00 and gave the company a “sell” rating in a research note on Friday, February 16th. Finally, Citigroup reaffirmed a “buy” rating and set a $81.00 target price (up from $70.00) on shares of Nu Skin Enterprises in a research note on Tuesday, January 23rd. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Nu Skin Enterprises has an average rating of “Hold” and a consensus target price of $71.29.
COPYRIGHT VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/04/07/nu-skin-enterprises-nus-general-counsel-d-matthew-dorny-sells-2000-shares.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.